Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BLUEPRINT MEDICINES

  • FDA Approval
  • Nov. 13, 2024, 03:02 UTC
  • 24
  • 0 comments

FDA approve AVAPRITINIB

Comment Full text

HOSPIRA

  • FDA Approval
  • Nov. 13, 2024, 03:02 UTC
  • 23
  • 0 comments

FDA approve LINEZOLID

Comment Full text

DEXCEL PHARMA

  • FDA Approval
  • Nov. 13, 2024, 03:02 UTC
  • 21
  • 0 comments

FDA approve OMEPRAZOLE

Comment Full text

AMNEAL PHARMS LLC

  • FDA Approval
  • Nov. 13, 2024, 03:02 UTC
  • 21
  • 0 comments

FDA approve MESALAMINE

Comment Full text

APOTEX INC

  • FDA Approval
  • Nov. 13, 2024, 03:02 UTC
  • 22
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

LUPIN LTD

  • FDA Approval
  • Nov. 13, 2024, 03:02 UTC
  • 16
  • 0 comments

FDA approve RALTEGRAVIR

Comment Full text

TEVA PHARMS INC

  • FDA Approval
  • Nov. 13, 2024, 03:02 UTC
  • 22
  • 0 comments

FDA approve FEDRATINIB

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Nov. 13, 2024, 03:02 UTC
  • 16
  • 0 comments

FDA approve PALIPERIDONE PALMITATE

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • Nov. 08, 2024, 16:22 UTC
  • 50
  • 0 comments

FDA approve NILOTINIB

Comment Full text

MSD MERCK CO

  • FDA Approval
  • Nov. 08, 2024, 16:09 UTC
  • 22
  • 0 comments

FDA approve DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Comment Full text
  • Previous
  • 224
  • 225
  • 226
  • 227
  • 228
  • Next

Search

News categories

  • Technical Exchange News(9912)
  • Event(410)
  • SEC News(167703)
  • FDA Approval(9356)
  • Company Report(721)
  • Business News(111580)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin